Profil
Scott Plevy served as Vice President at Janssen Pharmaceuticals, Inc. He then worked as Chief Scientific Officer at Synlogic, Inc. and Senda Biosciences, Inc. Currently, he is the Executive Vice President & Head-Gastroenterology at Protagonist Therapeutics, Inc. Dr. Plevy holds a doctorate degree from The Trustees of Columbia University in The City of New York.
Anciens postes connus de Scott Plevy
| Sociétés | Poste | Fin |
|---|---|---|
| PROTAGONIST THERAPEUTICS, INC. | Corporate Officer/Principal | 01/03/2024 |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Corporate Officer/Principal | 01/05/2019 |
Senda Biosciences, Inc.
Senda Biosciences, Inc. BiotechnologyHealth Technology Develops therapeutics to treat diseases | Directeur Technique/Scientifique/R&D | - |
| SYNLOGIC, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Scott Plevy
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Health Technology |
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protagonist Therapeutics, Inc.
Protagonist Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures peptide based therapeutic products | Health Technology |
Synlogic, Inc.
Synlogic, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Senda Biosciences, Inc.
Senda Biosciences, Inc. BiotechnologyHealth Technology Develops therapeutics to treat diseases | Health Technology |
















